Vivanza Biosciences Profit & Loss Annual

BSE: 530057 | NSE: - | ISIN: INE984E01035 | Sector: Biotechnology & Drugs
2.35 -0.06 (-2.49%)Updated : 13 Jun 2025
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Revenue 7.4227.8417.8110.40
Total Revenue 7.4227.8417.8110.40
Costof Revenue Total 6.8225.9516.519.65
Gross Profit 0.601.881.300.75
Selling/ General/ Admin Expenses Total 0.580.450.350.30
Depreciation/ Amortization 0.010.010.000.01
Other Operating Expenses Total 0.390.370.290.53
Total Operating Expense 7.8026.7817.1510.49
Operating Income -0.381.050.66-0.09
Interest Inc( Exp) Net- Non- Op Total -0.35-0.41-0.42-0.41
Other Net 0.060.050.480.83
Net Income Before Taxes -0.670.700.720.33
Provisionfor Income Taxes 0.010.150.120.00
Net Income After Taxes -0.670.550.600.33
Net Income Before Extra Items -0.670.550.600.33
Net Income -0.670.550.600.33
Income Availableto Com Excl Extra Ord -0.670.550.600.33
Income Availableto Com Incl Extra Ord -0.670.550.600.33
Diluted Net Income -0.670.550.600.33
Diluted Weighted Average Shares 4.003.914.004.00
Diluted EPS Excluding Extra Ord Items -0.170.140.150.08
Diluted Normalized EPS -0.170.140.150.08
period Length 12.0012.0012.0012.00
period Type ----
Unusual Expense( Income) --0.000.00
Total Adjustmentsto Net Income --0.00-
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,660.50+16.80(1.02%)
260.20+0.75(0.29%)
413.90-7.05 (-1.67%)
792.40-13.25 (-1.64%)